The Iran war has reduced the number of new 52-week highs on the NYSE and Nasdaq, and new 52-week lows now dominate across both exchanges. Among the 157 stocks hitting new 52-week lows, three penny ...
The stock market bulls are battling back to hold their ground at the Nasdaq’s 200-day moving average amid ongoing fighting in Iran and the Middle East. The strong showing on Monday came after ...
These companies' shares have fallen too far, offering investors an attractive opportunity.
Beyond Meat has fallen into penny-stock territory; is that an opportunity or a sign of risk?
After three straight years of huge gains, the Nasdaq-100 index has gotten stuck in 2026. Concerns about how artificial intelligence (AI) could negatively disrupt the global econom ...
StockStory.org on MSN
2 stocks under $50 worth your attention and 1 we ignore
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and ...
StockStory.org on MSN
3 stocks under $50 with open questions
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and ...
Aurora Innovation Inc. (NASDAQ:AUR) is one of the 11 most popular AI penny stocks to buy now. On February 17, Cantor Fitzgerald maintained an Overweight rating on Aurora Innovation (NASDAQ:AUR). The ...
Nano caps are publicly traded companies with market capitalizations under $50 million. Discover the risks and potential rewards these small-cap stocks offer investors.
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...
As of the March 6 closing, consensus sentiment for Indie Semiconductor Inc. (NASDAQ:INDI) was strongly bullish.
On February 17, Myles Minter from William Blair upgraded his rating on Neumora Therapeutics Inc. (NASDAQ:NMRA) from Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results